Market Cap 2.26B
Revenue (ttm) 441.54M
Net Income (ttm) 35.46M
EPS (ttm) N/A
PE Ratio 67.90
Forward PE 43.92
Profit Margin 8.03%
Debt to Equity Ratio 0.26
Volume 1,158,600
Avg Vol 1,303,154
Day's Range N/A - N/A
Shares Out 33.66M
Stochastic %K 18%
Beta 2.12
Analysts Strong Sell
Price Target $102.86

Latest News on TMDX

TransMedics Group, Inc. (TMDX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 9:23 PM EST - 4 weeks ago

TransMedics Group, Inc. (TMDX) Q4 2024 Earnings Call Transcript